Alliancebernstein L.P. Sells 3,318 Shares of Agilent Technologies, Inc. (NYSE:A)

Alliancebernstein L.P. trimmed its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 0.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 347,090 shares of the medical research company's stock after selling 3,318 shares during the quarter. Alliancebernstein L.P. owned about 0.12% of Agilent Technologies worth $46,628,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in A. CKW Financial Group increased its holdings in Agilent Technologies by 114.9% in the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company's stock valued at $25,000 after buying an additional 100 shares during the period. Global X Japan Co. Ltd. raised its position in Agilent Technologies by 161.1% during the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock valued at $25,000 after purchasing an additional 116 shares in the last quarter. Lee Danner & Bass Inc. acquired a new position in Agilent Technologies during the fourth quarter valued at approximately $29,000. Hanson & Doremus Investment Management lifted its stake in Agilent Technologies by 66.5% during the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock worth $35,000 after purchasing an additional 105 shares during the last quarter. Finally, OFI Invest Asset Management acquired a new stake in shares of Agilent Technologies in the 4th quarter valued at $37,000.

Insider Activity

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the firm's stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the transaction, the chief executive officer now directly owns 39,652 shares in the company, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Rodney Gonsalves sold 1,908 shares of Agilent Technologies stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the transaction, the vice president now directly owns 21,786 shares in the company, valued at approximately $2,657,456.28. This represents a 8.05 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,638 shares of company stock worth $731,229 in the last three months.

Remove Ads

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on A shares. Robert W. Baird decreased their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating on the stock in a report on Thursday, February 27th. StockNews.com raised shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Tuesday, December 24th. Citigroup increased their price target on Agilent Technologies to $165.00 and gave the company a "buy" rating in a research note on Thursday, December 19th. TD Cowen boosted their price objective on Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research report on Thursday. Finally, Barclays dropped their target price on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating for the company in a research report on Thursday. Seven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, Agilent Technologies has a consensus rating of "Moderate Buy" and an average price target of $146.25.

Agilent Technologies Trading Down 8.6 %

A stock traded down $9.21 during midday trading on Thursday, hitting $97.84. The stock had a trading volume of 850,485 shares, compared to its average volume of 1,827,994. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56. The firm has a market cap of $27.89 billion, a P/E ratio of 22.56, a price-to-earnings-growth ratio of 2.79 and a beta of 1.19. The business has a fifty day moving average price of $125.62 and a two-hundred day moving average price of $134.48. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $155.35.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The company had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. On average, sell-side analysts predict that Agilent Technologies, Inc. will post 5.57 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 1.01%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies's dividend payout ratio is presently 22.76%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.